Clinical Trials in Georgia

Showing 821-840 of 9,105 trials

Randomized Clinical Trial for Ewing Amputation in the VA

NCT05437562

This study follows the Pilot Investigation of Ewing Amputation for Veterans with PAD Undergoing a Below Knee Amputation. The 2 year pilot feasibility phase has concluded recruitment and enrollment. The current phase is a 5 year randomized study of Ewing Below Knee Amputation vs. Standard Below Knee Amputation. If Veterans participate, they will be randomized to either Ewing Amputation or Standard Below Knee Amputation. The scientific premise motivating this proposal is that Ewing Amputation is a promising surgical technique that may improve walking metrics in dysvascular Veterans by providing a better residual limb and improving pain and balance. In preparation of this proposal, we have formed multi-disciplinary surgical teams at each site, and we have been supported by a clinical trial planning meeting to garner the considerable expertise in rehabilitation and amputee assessment from VA and DOD experts to assist in the design of this proposal, testing the overall hypothesis that: Ewing Amputation can help Veterans walk.

Peripheral Arterial Disease

VA Office of Research and Development120 participantsStarted Feb 2026

Decatur, Georgia, United States • Nashville, Tennessee, United States • Houston, Texas, United States

RECRUITINGNA65 miles

Galleri® in the Medicare Population.

NCT05673018

This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.

Cancer

GRAIL, Inc.50,000 participantsStarted Jul 2024

Auburn, California, United States • Davis, California, United States • Elk Grove, California, United States +44 more locations

Randomized Clinical Trial for Ewing Amputation in the VA

Galleri® in the Medicare Population.

Find Trials by Condition in Georgia

Amplatzer Amulet LAAO vs. NOAC

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

CLOZAPINE Response in Biotype-1

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Shared Decision Making to Improve Goals of Care in the ED

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

FX Shoulder Prospective Clinical Study

Intermuscular Coherence as a Biomarker for ALS

Global Registry for Endovascular Aortic Treatment (GREAT)

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.